The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy.

Idiopathic dilated cardiomyopathy.

Enteroviruses and idiopathic dilated cardiomyopathy.

Addressing Health Disparities in Idiopathic Dilated Cardiomyopathy.

Dilated cardiomyopathy and progressive familial intrahepatic cholestasis.

Genetic Variations Leading to Familial Dilated Cardiomyopathy.

The epidemiology of idiopathic dilated cardiomyopathy in a biracial community.

Prevalence of celiac disease in children with idiopathic dilated cardiomyopathy.

Cardiac steatosis in patients with dilated cardiomyopathy.

Hormonal Profile in Patients With Dilated Cardiomyopathy.

Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA.

Prognostic features of children with idiopathic dilated cardiomyopathy.

Toward the primary prevention of idiopathic dilated cardiomyopathy.

Complexities of Genetic Testing in Familial Dilated Cardiomyopathy.

Effects of long-term xamoterol in idiopathic dilated cardiomyopathy.

Results of comprehensive diagnostic work-up in 'idiopathic' dilated cardiomyopathy.

Olanzapine Induced Dilated Cardiomyopathy.

LMNA-related dilated cardiomyopathy.

HIV-associated dilated cardiomyopathy.

GATA6 loss-of-function mutations contribute to familial dilated cardiomyopathy.

Diagnosis, prevalence, and screening of familial dilated cardiomyopathy.

Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy.

TBX5 loss-of-function mutation contributes to familial dilated cardiomyopathy.

Beta-adrenergic contractile reserve as a predictor of clinical outcome in patients with idiopathic dilated cardiomyopathy.

Frequency of left atrial thrombi by transesophageal echocardiography in idiopathic and in ischemic dilated cardiomyopathy.

Suggest Documents

Idiopathic dilated cardiomyopathy.

Enteroviruses and idiopathic dilated cardiomyopathy.

Addressing Health Disparities in Idiopathic Dilated Cardiomyopathy.

Dilated cardiomyopathy and progressive familial intrahepatic cholestasis.

Genetic Variations Leading to Familial Dilated Cardiomyopathy.

The epidemiology of idiopathic dilated cardiomyopathy in a biracial community.

Prevalence of celiac disease in children with idiopathic dilated cardiomyopathy.

Cardiac steatosis in patients with dilated cardiomyopathy.

Hormonal Profile in Patients With Dilated Cardiomyopathy.

Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA.

Prognostic features of children with idiopathic dilated cardiomyopathy.

Toward the primary prevention of idiopathic dilated cardiomyopathy.

Complexities of Genetic Testing in Familial Dilated Cardiomyopathy.

Effects of long-term xamoterol in idiopathic dilated cardiomyopathy.

Results of comprehensive diagnostic work-up in 'idiopathic' dilated cardiomyopathy.

Olanzapine Induced Dilated Cardiomyopathy.

LMNA-related dilated cardiomyopathy.

HIV-associated dilated cardiomyopathy.

GATA6 loss-of-function mutations contribute to familial dilated cardiomyopathy.

Diagnosis, prevalence, and screening of familial dilated cardiomyopathy.

Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy.

TBX5 loss-of-function mutation contributes to familial dilated cardiomyopathy.

Beta-adrenergic contractile reserve as a predictor of clinical outcome in patients with idiopathic dilated cardiomyopathy.

Frequency of left atrial thrombi by transesophageal echocardiography in idiopathic and in ischemic dilated cardiomyopathy.

The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy.

Recommend Documents

Follow Us